Cover Image

Epigenetics in non-small cell lung carcinomas

Objective. To perform a systematic review of the main epigenetic aberrations involved in non-small cell lung carcinomas' (NSCLC) diagnosis, progression, and therapeutics. Materials and methods. We performed a systematic review of the scientific literature on lung cancer epigenetics, focusing o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irlanda Peralta-Arrieta (Author), Leonel Armas-López (Author), Joaquín Zúñiga (Author), Federico Ávila-Moreno (Author)
Format:	Book
Published:	Instituto Nacional de Salud Pública, 2019-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma
by: Kaikai Gong, et al.
Published: (2020)

Personalized medicine and treatment approaches in non-small-cell lung carcinoma
by: Vadakara J, et al.
Published: (2012)

Role of circulating microRNAs in non-small cell lung carcinoma
by: Harshita Baranwal, et al.
Published: (2024)

The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
by: Hsiang-Ling Ho, et al.
Published: (2019)

Folate-Decorated Cross-Linked Cytochrome c Nanoparticles for Active Targeting of Non-Small Cell Lung Carcinoma (NSCLC)
by: Irivette Dominguez-Martinez, et al.
Published: (2022)

EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer
by: Xiyi Lu, et al.
Published: (2018)

Non-Small-Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia
by: Noorwati Sutandyo, et al.
Published: (2019)

Anticancer and apoptotic effects of theaflavin-3-gallate in non-small cell lung carcinoma
by: Da-Wei Li, et al.
Published: (2015)

Wedge resection and segmentectomy in patients with stage I non-small cell lung carcinoma
by: Konstantinos Reveliotis, et al.
Published: (2014)

Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer
by: Qiushi Wang, et al.
Published: (2022)

Rapid atrophy of cardiac left ventricular mass in patients with non‐small cell carcinoma of the lung
by: Seyyed Mohammad Reza Kazemi‐Bajestani, et al.
Published: (2019)

Atezolizumab-Induced Stevens-Johnson Syndrome in a Patient with Non-Small Cell Lung Carcinoma
by: Phatcharawat Chirasuthat, et al.
Published: (2018)

Pembrolizumab-Induced Lichen Planus on the Scalp of a Patient with Non-Small-Cell Lung Carcinoma
by: Aya Yamashita, et al.
Published: (2021)

Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non-small cell lung carcinoma
by: Tripti Nakra, et al.
Published: (2021)

Clinical implications of epigenetics in Renal Cell Carcinoma
by: Sawyer Reed, et al.
Published: (2022)

Epigenetic modifications in oral squamous cell carcinoma
by: Silas Antonio Juvencio de Freitas Filho, et al.
Published: (2018)

Alantolactone pyrazoline analogue inhibits cancer cell proliferation and induces apoptosis in non-small cell lung carcinoma cells
by: Jing lv, et al.
Published: (2015)

A systematic review: Molecular docking simulation of small molecules as anticancer non-small cell lung carcinoma drug candidates
by: Syahrul Hidayat, et al.
Published: (2022)

DNA damage and repair capacity in patients with non-small cell lung cancer treated with polychemotherapy
by: Anamarys Pandolfi Blanco, et al.
Published: (2018)

Epigenetic Scanning of <i>KEAP1</i> CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas
by: Federico Pio Fabrizio, et al.
Published: (2020)

Induced-Decay of Glycine Decarboxylase Transcripts as an Anticancer Therapeutic Strategy for Non-Small-Cell Lung Carcinoma
by: Jing Lin, et al.
Published: (2017)

Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients
by: Peng Cao, et al.
Published: (2022)

MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
by: Lisi Yuan, et al.
Published: (2023)

Scalp swelling: An unusual presentation of small cell lung carcinoma
by: Laxmikant Ramkumarsingh Tomar, et al.
Published: (2015)

Sintilimab for the treatment of non-small cell lung cancer
by: Lin Zhang, et al.
Published: (2022)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016)

Characteristics of non-small cell lung cancer: Differences by sex and hormonal status in a Mexican population
by: Vianey Rodríguez-Lara, et al.
Published: (2019)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Non-Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017)

Mutational profile by targeted next generation sequencing of non-small cell lung cancer in the Mexican population
by: Norma Hernández-Pedro, et al.
Published: (2019)

Evaluation of Epidermal Growth Factor Receptor Gene Mutations in an Iranian Population with Non-Small Cell Lung Carcinoma
by: Hamzeh Salmani, et al.
Published: (2022)

Intestinal Haemorrhage and Colitis Induced by Treatment With Osimertinib for Non-Small-Cell Lung Carcinoma: A Case Report
by: Wang Shujun, et al.
Published: (2022)

PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma
by: Min Luo, et al.
Published: (2021)

Unusual presentation of intraventricular metastases from small-cell carcinoma of the lung
by: Reddy Ravikanth, et al.
Published: (2019)

Submandibular gland metastasis as the initial manifestation of lung small cell carcinoma
by: Toshinori Iwai, et al.
Published: (2023)

Small Molecule Epigenetic Modulators in Pure Chemical Cell Fate Conversion
by: Zhao-Di Yuan, et al.
Published: (2020)

Anticancer effect of mountain ginseng Pharmacopuncture to the nude mouse of lung carcinoma induced by NCI-H460 human non-small cell lung cancer cells
by: Ki Rok Kwon
Published: (2010)

What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy
by: Paul Hofman
Published: (2021)

Current status of immunotherapy for non-small cell lung cancer
by: Tao Yang, et al.
Published: (2022)

PHARMACOECONOMIC ASPECTS OF NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
by: A. V. Rudakova, et al.
Published: (2017)